Wyoming, Montana, Colorado, South Dakota, and New Mexico citizens are struggling with their mental health so much so that the states have coined the term “suicide belt”.
We need to make mental health treatments available to all.
Psilocybin Therapy for Cancer and Depression
This occurred in patients with both curable and metastatic cancer.
Read moreFuture of Depression Treatment?
This article looks at some of the future treatment options for depression.
Read moreLSD, Anxiety and Depression
New research finds LSD effective in decreasing anxiety and depression.
Researchers report “effects were maximal 2 weeks after the second LSD session and sustained up to 16 weeks.”
Read morePsychedelics for Depression
Here’s the latest on how psychedelics may help treat depression.
Read moreDMT Effective for Depression
DMT is a powerful hallucinogen that can conjure visions of entities and alien worlds, but new research shows it can also treat depression.
Read moreIV Ketamine for Depression
New research shows that Ketamine intravenous therapy improves depression and reduces suicidal ideation.
Read moreDMT and Depression
The first clinical trial using DMT for depression has promising results.
Read moreMushrooms Instead of Prozac?
Newsweek says: Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
Read moreLargest Psilocybin Trial
The largest psilocybin trial to date finds the psychedelic is effective in treating serious depression.
Eagerly awaited results of the largest-ever study of psilocybin were announced Tuesday, with Compass Pathways revealing the psychedelic drug was highly efficacious as a therapy for treatment-resistant depression.
Read morePsilocybin, Depression and Cancer
COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients.
Within one week of a single administration of COMP360 psilocybin therapy, 50% of participants achieved remission in depression symptoms, which was sustained for the eight week follow-up period.
Read more